Skip to main content
. 2020 Dec 11;75(5):344–352. doi: 10.1055/a-1266-6602

Table 3. Comparison of diagnostic measures between DQ and patient documentation based on patient population.

Diagnostic measures Patients recruited by physicians who reported use of the measure Patients in whom the measures were performed
Physicians who reported routine use of the measure Physicians who reported not to routinely use the measure
N = 249 (%) % of patients % of patients P-value *
Body plethysmography 249 (100) 72.7  –   –  **
Chest X-ray 242 (97.2) 41.7  0 0.0436
Spirometry 211 (84.7) 30.3 34.2 0.7035
COPD Assessment Test 199 (79.9) 67.8 38.0 0.0002
AATD screening 210 (84.3)  1.0  7.7 0.0285
Differential blood count 203 (81.5)  6.9  6.7 0.3171
Blood eosinophils 192 (77.1)  8.3  3.5 0.3801
Total IgE 199 (79.9)  5.5  0 0.1274
Specific IgE 197 (79.1)  4.6  0 0.2107
Medical examination of the skin 185 (74.3)  3.2  4.7 0.6981
CT-scan of thorax 183 (73.5)  6.6  4.5 0.7652
mMRC (dyspnea assessment test) 107 (43.0) 50.5  0.7 < 0.0001

AATD = alpha-1 antitrypsin deficiency; CT = computed tomography; DQ = doctor’s questionnaire; IgE = immunoglobulin E

*

Fisher’s exact test

**

could not be calculated for this specific comparison